Is Hikma Pharmaceuticals PLC (HKMPY) a Buy, Sell, or Hold?
OTC : HKMPY
Hikma Pharmaceuticals PLC
$41.18 USD
-$0.82 (-1.95%)
- Volume
- 200
- Average Volume
- 161
- Market Capitalization
- $4.33B
- P/E Ratio
- 0.19
- Dividend Yield
- 3.98%
- Price Target
- Year High
- $55.33
- Year Low
- $31.80
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.45
- Current Ratio
- $1.82
| Source | Headline |
|---|---|
|
Hikma comments on Supreme Court of the United States' unanimous decision in favour of Hikma
LONDON, June 4, 2026 /PRNewswire/ -- Hikma Pharmaceuticals PLC, along with its wholly owned subsidiary Hikma Pharmaceuticals USA Inc., (Hikma) offered the following comments on today's unanimous decision by the Supreme Court of the United States effectively ending Amarin's patent infringement litigation against the company. "Hikma has long fought for patients and their access to safe, high-quality, and affordable medicines," said Sam Park, General Counsel, Hikma. prnewswire.com - 2026-06-04 17:39:00 |
|
Hikma Pharmaceuticals Announces Major Expansion in Ohio, Creating 350 New Jobs and Investing $267 Million
Cleveland and Columbus, Ohio, June 01, 2026 (GLOBE NEWSWIRE) -- COLUMBUS and CLEVELAND, Ohio - Ohio Governor Mike DeWine, along with Hikma Pharmaceuticals, JobsOhio, the City of Bedford, and other state and local partners, today announced plans for a significant expansion of Hikma's manufacturing operations in Ohio, reinforcing the company's commitment to the state's growing pharmaceutical and biomanufacturing industry. globenewswire.com - 2026-06-01 13:19:28 |
|
Hikma Pharmaceuticals PLC (HKMPY) Sales/ Trading Statement Call Transcript
Hikma Pharmaceuticals PLC (HKMPY) Sales/ Trading Statement Call Transcript seekingalpha.com - 2026-04-23 06:51:32 |
|
UK's Hikma Pharmaceuticals reiterates 2026 outlook despite higher costs from Iran war
Hikma Pharmaceuticals reiterated its 2026 guidance on Thursday, adding that, while it has faced some pressure on shipping, energy, and insurance costs due to the war in the Middle East, a key market for the firm, it was confident it could absorb the higher costs. reuters.com - 2026-04-23 02:27:19 |
